SCHEMBL9900968

SCHEMBL9900968

O=CCc1ccc(Oc2ccc(Cl)c(C(F)(F)F)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.48
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
PLA2G7 Q13093 6/20 0.45
AR P10275 1/20 0.43
CHEK2 O96017 2/20 0.42
RAF1 P04049 4/20 0.41
BRAF P15056 2/20 0.41
GPR84 Q9NQS5 1/20 0.41
KDR P35968 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18235654 0.87 PLA2G7 (0.48) IDO1PPARGPPARAPLA2G7AR
SCHEMBL875588 0.83 IDO1 (0.51) IDO1PPARGPPARAPLA2G7AR
SCHEMBL875436 0.83 POLB (0.44) IDO1PPARGPPARAPLA2G7BRAF
SCHEMBL4084168 0.82 IDO1 (0.57) IDO1PPARGPPARAGPR84KDR
SCHEMBL9104268 0.82 IDO1 (0.50) IDO1PPARGPPARAPLA2G7AR
SCHEMBL29918384 0.82 IDO1 (0.50) IDO1PPARGPPARAPLA2G7AR
SCHEMBL29985730 0.82 AR (0.46) PPARGPPARAARCHEK2RAF1
SCHEMBL875004 0.82 AR (0.46) PPARGPPARAARCHEK2RAF1
SCHEMBL17884158 0.82 IDO1 (0.50) IDO1PPARGPPARAPLA2G7AR
SCHEMBL875664 0.82 IDO1 (0.50) IDO1PPARGPPARAPLA2G7AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649053-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 Glaxo Group Limited (GB) 2013-10-16 EP disclosed
WO-2012076435-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 GLAXO GROUP LIMITED (GB) 2012-06-14 WO disclosed